These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22403718)
41. Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes. Fruci D; Butler RH; Greco G; Rovero P; Pazmany L; Vigneti E; Tosi R; Tanigaki N Immunogenetics; 1995; 42(2):123-8. PubMed ID: 7607703 [TBL] [Abstract][Full Text] [Related]
42. HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system. Uchanska-Ziegler B; Loll B; Fabian H; Hee CS; Saenger W; Ziegler A Eur J Cell Biol; 2012 Apr; 91(4):274-86. PubMed ID: 21665321 [TBL] [Abstract][Full Text] [Related]
43. An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. García F; Rognan D; Lamas JR; Marina A; López de Castro JA Tissue Antigens; 1998 Jan; 51(1):1-9. PubMed ID: 9459498 [TBL] [Abstract][Full Text] [Related]
44. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Madden DR; Gorga JC; Strominger JL; Wiley DC Cell; 1992 Sep; 70(6):1035-48. PubMed ID: 1525820 [TBL] [Abstract][Full Text] [Related]
45. Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation. Lim Kam Sian TCC; Indumathy S; Halim H; Greule A; Cryle MJ; Bowness P; Rossjohn J; Gras S; Purcell AW; Schittenhelm RB J Biol Chem; 2019 Dec; 294(52):20185-20195. PubMed ID: 31740583 [TBL] [Abstract][Full Text] [Related]
46. TCRB junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptides display conserved hydropathy profiles in the absence of primary sequence homology. May E; Duchmann R; Ackermann B; Meyer zum Büschenfelde KH; Märker-Hermann E Int Immunol; 1996 Nov; 8(11):1815-23. PubMed ID: 8943577 [TBL] [Abstract][Full Text] [Related]
47. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity. Sorrentino R; Böckmann RA; Fiorillo MT Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069 [TBL] [Abstract][Full Text] [Related]
48. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497 [TBL] [Abstract][Full Text] [Related]
49. Multi-modal Binding of a 'Self' Peptide by HLA-B*27:04 and B*27:05 Allelic Variants, but not B*27:09 or B*27:06 Variants: Fresh Support for Some Theories Explaining Differential Disease Association. Rana MK; Luthra-Guptasarma M Protein J; 2016 Oct; 35(5):346-353. PubMed ID: 27601175 [TBL] [Abstract][Full Text] [Related]
50. Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity but have limited peptide and T-cell epitope sharing with HLA-B27. Merino E; Montserrat V; Paradela A; López de Castro JA J Biol Chem; 2005 Oct; 280(43):35868-80. PubMed ID: 16115862 [TBL] [Abstract][Full Text] [Related]
51. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. Mear JP; Schreiber KL; Münz C; Zhu X; Stevanović S; Rammensee HG; Rowland-Jones SL; Colbert RA J Immunol; 1999 Dec; 163(12):6665-70. PubMed ID: 10586062 [TBL] [Abstract][Full Text] [Related]
52. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. Alvarez I; Martí M; Vázquez J; Camafeita E; Ogueta S; López de Castro JA J Biol Chem; 2001 Dec; 276(52):48740-7. PubMed ID: 11673468 [TBL] [Abstract][Full Text] [Related]
54. Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence the stability of peptide - MHC complexes. Carreno BM; Winter CC; Taurog JD; Hansen TH; Biddison WE Int Immunol; 1993 Apr; 5(4):353-60. PubMed ID: 8494822 [TBL] [Abstract][Full Text] [Related]
55. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. D'Amato M; Fiorillo MT; Carcassi C; Mathieu A; Zuccarelli A; Bitti PP; Tosi R; Sorrentino R Eur J Immunol; 1995 Nov; 25(11):3199-201. PubMed ID: 7489765 [TBL] [Abstract][Full Text] [Related]
56. Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue. Rognan D; Krebs S; Kuonen O; Lamas JR; López de Castro JA; Folkers G J Comput Aided Mol Des; 1997 Sep; 11(5):463-78. PubMed ID: 9385550 [TBL] [Abstract][Full Text] [Related]
57. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Galocha B; de Castro JA Arthritis Rheum; 2008 Feb; 58(2):401-12. PubMed ID: 18240209 [TBL] [Abstract][Full Text] [Related]
58. HLA-B27-bound peptide repertoires: their nature, origin and pathogenetic relevance. de Castro JA Adv Exp Med Biol; 2009; 649():196-209. PubMed ID: 19731630 [TBL] [Abstract][Full Text] [Related]
59. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues. Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004 [TBL] [Abstract][Full Text] [Related]
60. HLA-B27 Subtypes Predisposing to Ankylosing Spondylitis Accumulate in an Endoplasmic Reticulum-Derived Compartment Apart From the Peptide-Loading Complex. Jah N; Jobart-Malfait A; Ermoza K; Noteuil A; Chiocchia G; Breban M; André C Arthritis Rheumatol; 2020 Sep; 72(9):1534-1546. PubMed ID: 32270915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]